For years, DOT-regulated employers have been waiting for oral fluid drug testing to become a practical option. A recent FDA ruling has removed a significant regulatory barrier, bringing the industry closer to implementation and giving employers a reason to start preparing.
While DOT oral fluid testing is not yet available for routine use, this development could be a major step toward making it a reality.
At WorkforceQA, we’re following these changes closely and helping our clients understand what comes next.
What Changed?
The U.S. Food and Drug Administration (FDA) issued a final order eliminating the 510(k) premarket notification requirement for certain clinical toxicology test systems intended for use in federal drug testing programs. The order took effect upon publication in the Federal Register.
This requirement had been a significant obstacle for laboratories seeking certification to conduct federal oral fluid drug testing. Removing it clears an important hurdle and allows laboratories to move forward with the certification process.
Why does this matter to DOT-regulated employers?
The U.S. Department of Transportation (DOT) has authorized oral fluid as an alternative drug testing method under its regulations. However, implementation has been on hold while laboratories work toward the required certification through the Department of Health and Human Services (HHS).
Before DOT oral fluid testing can begin, at least two laboratories must be certified to support the program: a primary laboratory and a secondary laboratory.
The FDA’s decision removes a key obstacle to that process. Although some industry observers expect certification to move quickly, the timeline remains uncertain.
What Could Oral Fluid Testing Mean for Employers?
Once employers have the necessary laboratory certifications and meet implementation requirements, oral fluid testing could offer another option for managing DOT drug testing programs.
Potential benefits include:
- An alternative collection method: Oral fluid testing may provide flexibility in situations where urine collection presents challenges.
- Fewer collection complications: It may be particularly useful in certain situations involving shy bladder procedures or other collection difficulties, depending on applicable DOT requirements and employer policy.
- Observed collections: Oral fluid testing may offer an alternative in certain circumstances where direct observation is required or appropriate under the applicable rules.
- More options for program administration: Employers will have another testing method to consider when developing and managing their drug and alcohol testing programs.
Oral fluid testing will not replace urine testing across the board. Employers will need to understand when each method is permitted and how to apply the requirements correctly.
What Should DOT Employers Do Now?
The best time to prepare is before oral fluid testing becomes available. Employers should begin reviewing their current drug and alcohol testing policies and consider how they will manage the transition.
- Review and update your DOT drug testing policy.
Employers must address oral fluid testing in their written policies and procedures. This includes determining how oral fluid will fit into their existing testing program while maintaining compliance with DOT regulations.
- Establish a standing order for testing decisions.
Employers should develop a clear, documented process that identifies when oral fluid testing may be used. This standing order should address which testing reasons qualify for oral fluid collection, such as pre-employment, random, and other authorized testing circumstances.
It should also establish how the employer wants to handle situations in which an alternative collection method may be appropriate, including certain shy bladder or dry mouth situations and collections requiring direct observation. Each decision must follow applicable DOT requirements and the employer’s approved procedures.
A standing order helps ensure collection decisions are consistent, documented, and aligned with the employer’s policy rather than being made without clear direction at the collection site.
- Ensure a Designated Employer Representative (DER) is available.
Employers should plan for DER availability during collection activities so that questions can be addressed promptly when the standing order cannot be followed, or a situation requires employer direction.
Clear escalation procedures will help collection personnel understand whom to contact and how to proceed when an unexpected issue arises.
- Prepare collection personnel and internal teams.
Oral fluid testing will introduce new procedures, training considerations, and operational decisions. Employers should ensure the appropriate personnel understand the applicable requirements before authorizing the new method.
- Stay informed as implementation details develop.
Laboratory certification, federal guidance, and operational readiness will determine when DOT oral fluid testing can actually begin. Employers should avoid making changes based solely on anticipated dates or assuming the method is available before the required conditions are met.
Important: DOT Oral Fluid Testing Is Not Yet Available
Although the FDA’s final order removes a significant regulatory barrier, DOT oral fluid testing is not yet available for use under federal DOT drug testing requirements. At least two laboratories must first receive the required HHS certification, and employers must complete the necessary implementation steps before testing can begin.
Employers should not begin using oral fluid testing for DOT-mandated tests until it is officially authorized for implementation. In the meantime, this is an opportunity to review existing policies and prepare for the transition.
WorkforceQA Is Here to Help
Regulatory changes can create questions for employers, especially when new options affect established testing procedures. You don’t have to navigate those changes alone.
WorkforceQA is monitoring developments in DOT oral fluid testing and preparing resources to help clients understand their options and plan for implementation.
As the requirements become clearer, we will provide practical guidance, best-practice policy recommendations, educational webinars, and updates to help clients prepare their programs and teams.
Our goal is to help you make informed decisions, establish consistent procedures, and maintain a compliant, well-managed drug testing program as the industry evolves.
The bottom line: The FDA’s final order removes a significant barrier to DOT oral fluid testing, bringing implementation closer. The remaining steps still matter, but employers can use this time to review policies, plan standing orders, and prepare teams.
WorkforceQA has your back. We’ll continue to follow the developments and help you understand what they mean for your workforce, your policies, and your drug testing program.
